|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 9/58 | (2006.01) |
| A61K 9/50 | (2006.01) | ||
| A61K 9/54 | (2006.01) | ||
| A61K 9/62 | (2006.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 47/32 | (2006.01) | ||
| A61K 47/34 | (2006.01) | ||
| A61K 47/36 | (2006.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61P 25/14 | (2006.01) | ||
| A61P 25/18 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61P 25/30 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 1140105 |
| (13) | Kind of document | T |
| (96) | European patent application number | 99965527.7 |
| Date of filing the European patent application | 1999-12-20 | |
| (97) | Date of publication of the European application | 2001-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2003-10-22 |
| (46) | Date of publication of the claims translation | 2004-02-25 |
| (86) | Number | PCT/EP9910/257 |
| Date | 1999-12-20 |
| (87) | Number | WO 0003/8686 |
| Date | 2000-07-06 |
| (30) | Number | Date | Country code |
| 98204447 | 1998-12-24 | EP |
| (72) |
MCGEE, John Paul, Janssen Pharmaceutica N.V., BE
GILIS, Paul Marie V., Janssen Pharmaceutica N.V., BE
DE WEER, Marc M. G., Janssen Pharmaceutica N.V., BE
DE CONDE, Valentin F., Janssen Pharmaceutica N.V., BE
DE BRUIJN, Herman J. , Janssen Pharmaceutica N.V., BE
VAN DYCKE, Frederic A., Janssen Pharmaceutica N.V., BE
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kontroliuojamo atpalaidavimo galantamino kompozicija |
| CONTROLLED RELEASE GALANTAMINE COMPOSITION |
| Payment date | Validity (years) | Amount | |
| 2018-11-27 | 20 | 347.00 EUR |